NCT05010434 2023-09-21
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
10 trialsNCT05225116 2023-02-08
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT04104074 2020-07-07
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT04193696 2020-01-09
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Guangxi Medical University
Phase 2 Unknown
NCT03520257 2018-05-09
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
Guangxi Medical University
Phase 2 Unknown
NCT02580929 2015-10-22
Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients
Peking Union Medical College
Phase NA Unknown
NCT01328223 2011-04-04
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
China Medical University Hospital
Unknown
NCT01319942 2011-03-22
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
China Medical University Hospital
Unknown
NCT00960167 2009-10-15
A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital
Phase 1 Unknown